Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Cash & Equivalents (2018 - 2026)

Health Catalyst filings provide 9 years of Cash & Equivalents readings, the most recent being $59.9 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 82.49% to $59.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $59.9 million, a 82.49% decrease, with the full-year FY2025 number at $50.8 million, down 79.65% from a year prior.
  • Cash & Equivalents hit $59.9 million in Q1 2026 for Health Catalyst, up from $50.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $342.0 million in Q1 2025 to a low of $40.3 million in Q3 2025.
  • Median Cash & Equivalents over the past 5 years was $124.2 million (2022), compared with a mean of $152.4 million.
  • Biggest five-year swings in Cash & Equivalents: surged 245.71% in 2024 and later plummeted 87.72% in 2025.
  • Health Catalyst's Cash & Equivalents stood at $116.3 million in 2022, then fell by 8.63% to $106.3 million in 2023, then surged by 134.9% to $249.6 million in 2024, then tumbled by 79.65% to $50.8 million in 2025, then grew by 17.81% to $59.9 million in 2026.
  • The last three reported values for Cash & Equivalents were $59.9 million (Q1 2026), $50.8 million (Q4 2025), and $40.3 million (Q3 2025) per Business Quant data.